Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$310,336,944
+$65,821,610 QoQ
Shares Held
258,737
-2.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
3.44%
of 13F equity value
Holder Rank
#208
of 4,605 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Compagnie Lombard Odier SCmA holds $723,906,825 across 10 Drug Manufacturers - General names. LLY ranks #1 (42.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
258,737 | $310,336,944 | |
| 2 | MRK |
Merck & Co., Inc.
|
790,796 | $101,617,285 | |
| 3 | JNJ |
Johnson & Johnson
|
375,199 | $95,289,289 | |
| 4 | AZN |
Astrazeneca PLC
|
395,004 | $74,900,656 | |
| 5 | ABBV |
AbbVie Inc.
|
276,074 | $69,471,261 | |
| 6 | AMGN |
Amgen Inc
|
171,214 | $62,000,013 | |
| 7 | PFE |
Pfizer Inc
|
382,649 | $9,214,187 | |
| 8 | NVO |
Novo Nordisk A S
|
20,029 | $960,190 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,336,944 | 258,737 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $244,515,334 | 265,844 | Shares | Defined | 2026-04-15 | |
| 2025-12-31 | $275,977,848 | 256,800 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $201,704,391 | 264,357 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $184,695,600 | 236,932 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $182,411,307 | 220,861 | Shares | Defined | 2025-04-16 | |
| 2024-12-31 | $98,545,028 | 127,649 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $63,224,221 | 71,364 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $59,633,757 | 65,866 | Shares | Defined | 2024-07-18 | |
| 2024-03-31 | $43,437,396 | 55,835 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $24,051,861 | 41,261 | Shares | Defined | 2024-01-16 | |
| 2023-09-30 | $9,334,244 | 17,378 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $2,928,311 | 6,244 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $1,128,478 | 3,286 | Shares | Defined | 2023-05-01 | |
| 2022-12-31 | $612,782 | 1,675 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $284,548 | 880 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $446,140 | 1,376 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $290,951 | 1,016 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $332,845 | 1,205 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $209,099 | 905 | Shares | Defined | 2021-10-28 | |
| 2021-06-30 | $207,715 | 905 | Shares | Defined | 2021-07-15 | |
| 2021-03-31 | $169,072 | 905 | Shares | Defined | 2021-04-23 | |
| 2020-12-31 | $296,314 | 1,755 | Shares | Defined | 2021-02-09 | |
| 2020-06-30 | $0 | 0 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||